sugar and semaglutide Weekly improves blood weight in adults with type 1 diabetes, clinical trial finds Benefits of Semaglutide for Medical

No retatrutide has not received MHRA marketing authorisation and is not available through NHS prescribing

Tablets should only be swallowed whole, not broken, chewed or crushed

Protein powders, amino acids, specific vitamins and minerals can be used to complement a balanced diet

Summary: Retatrutide is an unlicensed investigational drug in the UK, administered as a once-weekly subcutaneous injection only within approved clinical trials under medical supervision

Semaglutide was initially only FDA-approved to help with blood sugar control in type 2 diabetes and to lower the risk of major cardiovascular events (like heart attack and stroke) in people with both type 2 diabetes and heart disease

Less common serious side effects can include pancreatitis and gallbladder attacks